biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs

Bullboard Posts

Comment by Sniper007on Jan 18, 2013 1:41pm

167 Views

Post# 20857743

RE: RE: GSK sitting on the sidelines?

Sorry amob, the "two days...I have my reasons" was from an earlier JD post. I would like to know his reason too but I somehow don't think we'll hear about it.

In terms of my "call", these low levels will most likely not be around once the TTU and Shire data is released and we all suspect the data to be released any day between now and six weeks. That will be when we all say "I told you so". It is believed amongst many here that the data will be very positive news. I simply say to "buy now" because you don't want to get caught with your pants down and hindsight is always 20/20. As JD said "belly up". I continue to buy as much as I can get my hands on.

Bullboard Posts

Advancing flagship Ishkõday Gold Project in Ontario